GCRI · Science
Molecular and life sciences
Molecular and life sciences study the structure and function of living systems from genes and proteins to cells and organisms. They underpin the understanding of pathogens, resistance, toxicity and biological innovation. Biotechnology and Biosecurity stewards this page for the Nexus Consortium.
The workspace for molecular and life sciences.
Oversight register
The Global Centre for Risk and Innovation (GCRI) · Molecular and life sciences · Run R-9766 · Example interface, not a record
Institutional reviews
capacity and oversight only
| Project P-644 | Institutional committee | Level 2 | Q3 | Approved |
| Project P-343 | Institutional committee | Level 2 | Q3 | Approved |
| Project P-295 | Institutional committee | Level 2 | Q3 | Approved |
| Project P-608 | Institutional committee | Level 2 | Q2 | Approved |
Training coverage
GCRI · Oversight register. Oversight register: example names and illustrative values, not a record.
What molecular and life sciences covers.
- 01
Core methods
genome sequencing and assembly; phylogenetic analysis; functional assays; proteomics and metabolomics; cell and tissue culture; bioinformatic pipelines.
- 02
Data and instruments
sequencing instruments; public sequence repositories; biobanks; laboratory assays; structural biology instruments.
- 03
Validation
Results are confirmed through biological replicates, independent laboratories and orthogonal assays. Reference standards and proficiency testing check analytical accuracy.
- 04
Limits
Laboratory findings do not always translate to organisms or populations. Sampling bias in sequence databases limits generalisation.
- 05
Use in risk decisions
Life sciences support pathogen characterisation, antimicrobial resistance tracking and biosecurity assessment. They inform how biological threats might spread through health, agriculture and trade.
Life sciences research is governed by biosafety and responsible-use frameworks.
| Reference | What it sets |
|---|---|
| WHO Laboratory Biosafety Manual | Risk-based biosafety practice in laboratories |
| WHO Global guidance framework for the responsible use of the life sciences | Governance of dual-use research risks |
| Biological Weapons Convention | Prohibition of biological weapons and confidence-building measures |
| Cartagena Protocol on Biosafety | Transboundary movement of living modified organisms |
Pages here describe capacity and oversight. They give no technical detail that would raise biological risk.
How the process runs.
Process
Molecular and life sciences: Life-science research oversight
Capacity and oversight only, following the WHO Laboratory biosafety manual (4th edition) and WHO life sciences framework, with no methods, agents or protocols.
01 Institution
- 01ProposalDatasetA research institution submits a proposal for review. The place is set by the page.
- 02Institutional committeeGate · The institutionA biosafety committee is an independent institutional review group, reporting to senior management. Review follows national rules.
- 03Conditions: risk control measuresStepA risk assessment sets the measures: core requirements, heightened control measures or maximum containment, not one biosafety level.
- 04Training and competenceStepActual risk depends on the agent, the procedure and staff competency. Training and personnel competence have their own section.
02 Assurance
- 05Audit and inspectionGateMany labs run cooperative inspections: periodic self-audits plus a rarer, deeper evaluation with the biosafety officer or committee.
- 06Emergency and incident responseStepThe manual covers emergency and incident response at each level of measures. External reporting of incidents depends on national rules.
03 National
- 07National oversightDecision · National DeskThe WHO framework is for those who govern biorisks, such as policy makers and regulators. National bodies set national rules.
Neutral outline of a published external standard or method, from its issuing body. Not a record of operation. Nexus does not perform, certify or approve any step shown. A gate or decision belongs to the party the source names. The Biological Weapons Convention is not drawn in this flow. The framework is the WHO global guidance framework for the responsible use of the life sciences.
Capacity and oversight, not protocols.
For systemic risk the life sciences matter through capacity: the ability to identify a pathogen, develop countermeasures and manufacture them at scale. They also matter through oversight: how institutions review research with misuse potential. Analysis at GCRI addresses these at the level of systems and governance.
- Assess diagnostic and countermeasure capacity as part of preparedness.
- Treat oversight institutions (biosafety committees, review boards) as risk controls to assess.
- Keep technical biological detail out of public outputs.
- Oversight work sits on Biotechnology and Biosecurity.
Platforms that apply this method.
Who maintains this page.
Biotechnology and Biosecurity stewards molecular and life sciences: it keeps this description current and reviews how the method is applied across the platforms.
Where this page’s references lead.
The bodies and documents this page is read against. Status and editions change; each link goes to the issuing body.
Questions and answers.
Why does one institution host every method page?
How do I suggest a correction to a method page?
Contribute evidence from this page.
Reports is the Consortium’s quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.
- EmailGateway GW-GCRISend it from this pageEvidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen depositDeposit it and submit to the communityPublish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- ReportsGCRISee every way to contributeThe contribution types, how each is reviewed, what credit you receive, the licence and what is never accepted.
Never send personal data, sensitive infrastructure detail or anything you have no right to share. A contribution is reviewed before use; sending it confers no authorship or editorial rights, and sponsorship never buys a finding.
Bring a method, a dataset or a question.
Information and enquiries are open today. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.
Legal documents.
Maps, data and figures on this site are shown for context and general information. They are not advice, forecasts or warnings; the limits of the information are set out in the Disclaimers and Data Notices.